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Analysis of the binding of p-chlorophenyl-methoxybenzyl-ketoxime 
(CPMB-Oxime) to mitochondrial cytochrome c reductase 
Cytochrome L’ reducrase is inhibited by p-chlorophenyl-methoxybenzyl-ketoximr (CPM&oxime). CPMB-oxime induces a red-shift of the reduced 
spectrum of cytochrome h. The inhibitar blocks the oxidation of ubihydroquinone at the Qr center of this enzyme in a non-competitive way. The 
binding stoichiometry equals one inhibitor molecule per QP center. The apparent Kd in a red-shift assay was 6.9 +0.6&M. All binding characteristics 
analysed in this study were very similar to those of the E-,&methoxyacrylate inhibitors, although the chemical structure is different from these inhibi- 
tors. This result is interpreted as a support for the inhibitory mechanism based on the model of a ‘catalytic switch’ propused recently for the E-/F 
methoxyacrylate inhibitors (MOA-inhibitors (Brandt and van Jagow. Eur. J. Biochem. (1991) 195, 163-170). 
Cytochrome c reductase; Inhibitor; CPMB-oxime; Myxothiazol; Red-shift 
A large number of inhibitors has been described for 
mitochondrial cytochrome c reductase, which vary con- 
siderably in their chemical structure. Certain structural 
elements were found to be correlated to specific effects 
on the optical spectrum of reduced cytochrome has well 
as the EPR spectrum and midpoint potential of the 
iron-sulfur cluster [I]. Following this line the inhibitors 
of the ubih~droqu~no~e oxidation center as defined by 
the Q-cycle mechanism f2] can be classified into three 
groups: (i) the hyriroxynaphthoquinoile analogs (un- 
d~cylhydroxyna~hthoquinone, undeoylhydroxybenzo- 
thiazol, etc.), which change the EPR spectrum and the 
redox potential of the ‘Rieske’ iron-sulfur cluster [3]; 
(ii) the chromone inhibitors (stigmatellin) which change 
the EPR spectrum and the rcdax potential of the 
‘Rieske’ iron-sulfur cluster and induce a red-shift of the 
optical spectrum of the reduced cytochrome 6; (iii) the 
E-P-methoxyacrylate (MOA) inhibitors (myxothiazol, 
strobilurin), which induce a red-shift af the reduced 
cytochrome b. 
Analysis of the binding characteristics of the fatter 
class, revealed a non-competitive type of iilh~bitjon [4]. 
As this means that blockage of electron transfer by this 
type of inhibitor is not based on displacement of the 
substrate ubiquinol, the question of the inhibitory 
mechanism arises. 
According to the recently proposed ‘catalytic switch’ 
the inhibitors block the ubihydroquinone oxidation at 
the Q~I center by stabifising one of two redox-dependent 
conformaiional states of the enzyme [S]. If this is the 
case, the distortion of the ligang field of haem by,, 
which rcsutts in the observed red-shift of the spectrum, 
correlates to the ‘b-state’ conformation. 
This assumption is supported by the data presented in 
this paper on the binding characteristics of a new in- 
hibitor of the mitochondrial cytochrome c reductase, 
which is not related structurally to any of the inhibitors 
described so far, but which has binding characteristics 
almost identical to those of the E-P-methoxyacrylates. 
2. MATERIALS AND METHODS 
,~b~~~e~~ff~i~~~s~ CPMB-oxime, i-7.i‘htorophenyl-rnelho~yb~n~~l-ke- 
rouime; %lOA, ~-~-rnerho~ya~rylat2: NBW, nonylubihydroyuinane: 
Qh center. inner (negative sidt- or the membrane) ubiquinonc reaction 
center of the mitochondrial cytochrorne (‘ reductaae; Q,, center, outer 
(positive iide of the rncmbrnne) ubiquinone reaction center of the 
mitochondrial cytochrome c rcductaie 
Ni inhibitori were used as cthanolic stock ~oiufions. The concen- 
trations wcrr determined speftrophorornerrically in ethanol using the 
following wavelength\: antimycin (Bochringer, ~~~allnl~eirn) at 336 nm 
(c = 4.8 rnM '-cm '); stl-obilurin 4 (Pro<. Anke, Kaiscr\laurern) at 
292 nm (1 2 21.9 mW ’ .crnm ‘); CPM&Oximc (Prof. Bcechep, 
Aberysthwyrh) a~ 250 nm (t = 15.6 mM~~‘~crn~‘). 
1 hr substrate-analoEue nonylubiquinone (~,r,~,~~~(r ,,,,, - 4.2 mW ’ 
cm ‘) ~a5 synthesized ai described pre\louily 141. 
AIX other chemicals were oc the highest purity available. 
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Fi g. 1, Molecular structure and UWsprctrum of CPMB-wirne. The 
specrrum of a 50 /rM solution of CPMB-o~irne was re~ordcd. 
~ 20°C. The concentration was determined by the reduced minus ox- 
idLed hacm h spectrum at X2-575 nm (t =2X.5 mW ’ ~crn ‘). 
The apparent ICI{, values ai inhibitor concentration resulting in 
half-maximal 0~ consumption late of uncoupled bovine heart 
mitoch~~l~dria respiring on succinate were determined as described 
pre\iously [4]‘ 
Red-shift spectra were recorded in a Shimadzu UV-300 double- 
beam 5pectrophotometer as the spectral difference of the dithionite- 
reduced ewyme will1 and without a saturating amount of inhibitor. 
Titration of binding was followed as the spectral shift of the 
dithionite-reduced enzyme at 568-558 nm in the dual-wavelength 
mode. Either ethanol or nonylubiyuinone in the same volume 01 
ethanol were added. C‘ytochrome c reduclase and quinone were reduc- 
ed by adding a few grains of sodium dithionite. The data were ana- 
lywd as described prcviottsly [4]. 
The r-elative exrent of reduction of the cytochromcs of cyrochrome 
< reductaw \*a\ determined under caryin conditions using a stirred 
cuverre m a ShimadLu UV-300 double-beam spectrophot~~rilcter in the 
dual wavelength mode, at 562-575 nm for cytochrome b and at 
AAjO.O1 A B C D . . 
NBH 
-Inh. *Ant. 
‘#~---._\ 
+CPMB-Oxim +Ant. 
E 
NBH 
+ CPMB-Oxim 
I I NW 
Cyt b r~-~-__^_. 1 
1 1 
i-l-- 
NrH ,/-- 
I 
,,f ’ 
562-575 ! l 
m 2 I -ii 
3. RESULTS 
3.1. General properties 
The UV spectrum of CPMB-oxime in ethanol has a 
featureless maximum at 250 nm (Fig. I). The extinction 
coefficient at this wavelength was determined as 15.6 
mM_‘-cm-‘. Besides the content of aromatic and 
merhoxy residues, the structural formula shows no 
similarities to any MOA inhibitor or the substrate 
ubihydroquinone. 
3.2. Inhibition of electron transfet 
CPMB-oxime is a potent inhibitor of the steady state 
activity of cytochrome L’ reductase. The apparent ICSO 
value was 0.2 WM (data not shown), which is com- 
parable to the weakest MOA inhibitor Oudemansin A 
[4]. In order to determine, whether CPMB-oxime is a 
QP or a QN center inhibitor, we tested its effect on the 
reduction of cytochromes 17 and cl. Fig. 2 shows that 
neither the QN center inhibitor antimycin, (Fig. 2B) nor 
CPMB-oxime (Fig. ZC) alone slowed down cytochrome 
b reduction significantly. The extent of cytochrome 0 
reduction was increased from about 5OO;o to approx- 
imately 8Ooio by antimycin, since equilibration via the 
QN site is blocked by this inhibitor. The extent of 
cytochrome b reduction was decreased to 3Oulo by 
CPMB-oxime, which could be referred to a shift of the 
midpoint potential of cytochrome b. When both in- 
hibitors were added prior to substrate, the rate of reduc- 
tion was slowed down drastically. 
ComplenleIltary results were obtained, when the 
kinetics of cytochrome ~‘1 reduction were monitored: 
with antimycin only the extent of fast cytochrome cl 
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Fig. 2. Reduction kinetics of the intrinsic heme centrea of cytochrome c reductase. The reduction of cytochrome hand cytochrorne (‘1 was determin- 
ed at a reductase concentration of 1 rM in cytochrome ct. Buffer: 20 mM K’IMOPS, 0.05% Triton X-100, 100 mM NaCi, 2 mM NaN,, pH 7.2. 
Plfter prrincubation with inhibitor, 7 FM of NBH was added. The maximal amount of reductble cytochrome \~‘as determined by adding a fe& grains 
of dithionite after the cxperirncnt. (A) no inhibitor: (ES) 15 pM antimycin; (C) 37 phi CPM&&me; (I>) I5 b~%‘l anl~mycin, 37 &I CPhlU-ouime. 
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Fig. 3. Red-shift spectrum of CPMB-oxime. The spectrum was 
recorded ai a reductase concentration of 3 pM in cytochromc cl, In- 
hibitor was added to a final concentration of 70 pM. Buffer: 100 mM 
K’IMOPS, 0.05% Triton X-100, 100 mM NaCI, 2 mM NaNl, 
reduction decreased (Fig. 2B, [4]), but in the presence of 
CPMB-oxime much slower reduction-kinetics were 
observed (Fig. 2C,D) 
Taken into account that complete inhibition cannot 
be obtained with such a low affinity inhibitor in this 
type of experiment, the results identify CPMB-oxime 
unequivocally as a QP site inhibitor, conferring an in- 
complete ‘double kill’. 
This observation [7] is known to be specific for the 
combined action of a QN and a Qp center inhibitor and 
therefore demonstrated that CPMB-oxime is a Qr 
center inhibitor. 
0.15 T bound/t free*snzymef (l/‘j.tHl 
Fig. 4. Scatchard plot of red-shift tritrations. (U) no additions; 
(x-x), 0.8 mM NBH added. Experimental conditions and concen- 
trations as described in Fig. 3. Enzyme refers to the monomer of 
cytochrome c reductase. 
3.3. Red-sheet s~~ctru~n 
The red-shift spectrum of reduced cytochrome b in 
the presence of CPMB-oxime (Fig. 3) shows maxima at 
434 nm and 568 nm and minima at 424 nm and 559 nm. 
These values and the overall shape of the spectrum are 
almost identical to those reported for MOA inhibitors 
[4]. The only difference was a somewhat broader 
trough in the a-region of the shift spectrum. The max- 
imum-minimum absorbance difference was 4 mOD/ 
i&i in the w-region and 22 mOD/@M in the Soret-region 
of the spectrum. The value for the a-region is slightly 
lower and the value for the Soret-region is twice as high 
when compared to the E-~-methoxyacrylates. However, 
the Soretia-ratio shows also considerable variation, 
when different E-/3-methoxyacrylates are compared [4]. 
3 .J. Binding analy,si.s 
From quantitative red-shift titrations (Fig. 4) we 
determined an apparent Kd of 6.9 + 0.6 PM (n = 6). The 
binding stoichiometry was 0.99 t 0.01 per QP centre in 
these experiments. In the presence of saturating 
amounts of nonyllibih~droquinone the apparent Kd was 
raised to 8.8 _t 0.7 yM (n= 3), which is about 30’5’0 
higher than without the substrate; i.e. the inhibitor was 
not displaced by the substrate, but a shift of the & 
similar to that observed for the E-@-methoxyacrylates 
occurred. 
4. DISCUSSION 
CPMB-oxime has a relatively low affinity to 
cytochrome c reductase. However, it inhibits effectively 
the QP center of mitochondrial cytochrome c reductase. 
The red-shift spectrum is almost identical to those 
reported for the MOA inhibitors 141. Like these in- 
hibitors CPM&oxime is non-competitive to the 
substrate ubihydroquinone but its binding is influenced 
by simultaneous binding of substrate. 
The analysis presented in this paper reveals that 
CPMB-oxime represents another type of a specific, 
non-competitive inhibitor of the QP center of the 
mitochondrial cytochrome c reductase. Although there 
are essentially no structural similarities, we have found 
binding characteristics of CPMB-oxime which are 
almost identical to those of the E-/3-methoxyacrylates. 
Of particular interest is that both types of inhibitors in- 
duce nearly the same red-shift of reduced cytochrome 
b. 
The observed differences in the red shift spectra are 
not likely to be in conflict with this conclusion, not only 
because similar variations occur when different E-P- 
methoxyacrylates are compared [4], but also because 
the lipidation and thereby the structural rigidity of the 
multiprotein complex affects the absolute and relative 
sizes of the Soret/ a-shift spectra of E-fl-methoxy- 
acrylate inhibitors (manuscript in preparation). There- 
fore, the shift amplitude should be indicative for the 
217 
Volume 287, nurnbcr I .Z FEBS LET 
‘elasticity’ of the conformational block, which is ef- 
fected by the inhibitor molecule. and which is conse- 
quently dependent on its structure. 
If the red-shift spectrum is interpreted as simply 
reflecting a structural distortion of the ligand-fields of 
the two haem 0 centres imposed by the binding of the 
inhibitor molecule, the conclusion would be that two in- 
hibitors binding and interacting differently in the Qrl 
pocket happen to have a similar spectral effect. A more 
likely explanation is the inhibitory mechanism we pro- 
posed recently for the E-d-methoxyacrylates [5]: if both 
types of inhibitor would trap the same conformational 
state of a ‘catalytic switch’ of the Qr> center, the rcd- 
shift would be directly correlated to a structural proper- 
ty of the protein allowing some Lariability of the struc- 
ture of the inhibitor molecules. 
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